Standard InChI: InChI=1S/C42H46FN9O8S/c1-60-33-23-27(43)16-17-29(33)38-46-25-47-42(50-38)48-28-11-8-10-26(22-28)24-61(2,59)51-36(55)15-7-5-3-4-6-14-34(53)45-21-20-44-31-13-9-12-30-37(31)41(58)52(40(30)57)32-18-19-35(54)49-39(32)56/h8-13,16-17,22-23,25,32,44H,3-7,14-15,18-21,24H2,1-2H3,(H,45,53)(H,49,54,56)(H,46,47,48,50)
Standard InChI Key: SRVYTIFEXUTLAJ-UHFFFAOYSA-N
Associated Targets(Human)
CDK9/cyclin T1 2643 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MV4-11 7307 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MOLM-13 2241 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HCT-116 91556 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
A549 127892 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HepG2 196354 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MCF7 126967 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/CDK9 113 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cyclin-dependent kinase 9 2495 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 7 8 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 6 113 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 2 25 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 1 7 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
B16 5829 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cyclin-dependent kinase 9 2 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Unknown
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 855.95
Molecular Weight (Monoisotopic): 855.3174
AlogP: 4.91
#Rotatable Bonds: 19
Polar Surface Area: 231.11
Molecular Species: NEUTRAL
HBA: 13
HBD: 4
#RO5 Violations: 2
HBA (Lipinski): 17
HBD (Lipinski): 4
#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.54
CX Basic pKa: 2.42
CX LogP: 3.73
CX LogD: 3.73
Aromatic Rings: 4
Heavy Atoms: 61
QED Weighted: 0.07
Np Likeness Score: -0.97
References
1.Qiu X, Li Y, Yu B, Ren J, Huang H, Wang M, Ding H, Li Z, Wang J, Bian J.. (2021) Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion., 211 [PMID:33338869][10.1016/j.ejmech.2020.113091]